---
$id: https://graph.org.ai/products/commodity/51361903
$type: Product
source: UNSPSC
code: "51361903"
title: "Amobarbital or amylobarbitone"
class: "51361900"
classTitle: "Hypnotic barbiturates"
family: "51360000"
familyTitle: "Hypnotics"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Amobarbital or amylobarbitone

**UNSPSC Code**: 51361903
**Class**: [Hypnotic barbiturates](Hypnotic barbiturates.mdx)
**Family**: [Hypnotics](../Hypnotics.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a barbiturate with the molecular formula C11H18N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier GWH6IJ239E, chemically known as 2,4,6(1h,3h,5h)-pyrimidinetrione, 5-ethyl-5-(3-methylbutyl)- but generally known as amobarbital, which bears US NIH Compound Identifier 2164. amobarbital most often arises in base, natrium, and sodium forms. European Medicines Agency schedules Amobarbital in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05468MIG. The term AMOBARBITAL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 30, No. 10 1976, List 16). World Health Organization schedules amobarbital in its Anatomical Therapeutic Chemical (ATC) Classification. AMOBARBITAL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Amobarbital or amylobarbitone bears US NLM identifiers UMLS ID C0002640 and NCI Concept Code C76523. SMILES: CCC1(C(=O)NC(=O)NC1=O)CCC(C)C.

